These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6473980)

  • 21. Differential hemodynamic response to vasodilators in a patient with pulmonary hypertension: case report.
    Zaloga GP; Hughes P; Cohen D; Chernow B; Rainey TG; Lake CR
    Mil Med; 1983 May; 148(5):426-9. PubMed ID: 6408523
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sildenafil treatment of unilateral pulmonary edema and pulmonary hypertension in pulmonary artery agenesis].
    Rodríguez-Gómez F; Martín I; Sánchez A; Pujol E
    Rev Esp Cardiol; 2006 Dec; 59(12):1347-9. PubMed ID: 17194435
    [No Abstract]   [Full Text] [Related]  

  • 23. Adrenomedullin in the treatment of pulmonary hypertension.
    Nagaya N; Kangawa K
    Peptides; 2004 Nov; 25(11):2013-8. PubMed ID: 15501535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.
    Fitzgerald RK; Oishi P; Ovadia B; Ross GA; Reinhartz O; Johengen MJ; Fineman JR
    Pediatr Crit Care Med; 2004 Nov; 5(6):571-7. PubMed ID: 15530195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel use of sildenafil in the treatment of portopulmonary hypertension.
    Chua R; Keogh A; Miyashita M
    J Heart Lung Transplant; 2005 Apr; 24(4):498-500. PubMed ID: 15797756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension.
    Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L
    Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of chronic pulmonary hypertension by vasodilators. Symposium: E.S.C. Working Group on Pulmonary Circulation. 9 September 1987, Santiago de Compostela, Spain.Proceedings.
    Eur Heart J; 1988 Sep; 9 Suppl J():1-43. PubMed ID: 3181181
    [No Abstract]   [Full Text] [Related]  

  • 28. [Selective vasodilation in the lung. Sildenafil improves physical capacity and prognosis].
    MMW Fortschr Med; 2007 May; 149(22):45. PubMed ID: 18069228
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary pulmonary hypertension: a therapeutic dilemma.
    Khalilullah M; Bahl VK
    Indian Heart J; 1985; 37(2):75-7. PubMed ID: 4029995
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of pulmonary arterial hypertension associated with chronic obstructive pulmonary disease makes sense - contra].
    Köhler D
    Dtsch Med Wochenschr; 2008 Apr; 133(14):721. PubMed ID: 18363193
    [No Abstract]   [Full Text] [Related]  

  • 31. [Individual approach to vasodilator treatment of pulmonary hypertension in chronic bronchitis].
    Volkova LI; Shteĭngart IuN
    Klin Med (Mosk); 1994; 72(6):66-7. PubMed ID: 7898022
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies.
    Gordeuk VR
    Haematologica; 2005 Apr; 90(4):433-4. PubMed ID: 15820926
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacological aspects within the scope of pulmonary hypertension].
    Kraupp O
    Med Welt; 1972 Jul; 23(29):1006-8. PubMed ID: 5077680
    [No Abstract]   [Full Text] [Related]  

  • 34. Aerosolized iloprost for primary pulmonary hypertension.
    Ewert R; Wensel R; Opitz CF
    N Engl J Med; 2000 Nov; 343(19):1421-2. PubMed ID: 11183891
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.
    Raja SG; Danton MD; MacArthur KJ; Pollock JC
    J Cardiothorac Vasc Anesth; 2006 Oct; 20(5):722-35. PubMed ID: 17023298
    [No Abstract]   [Full Text] [Related]  

  • 36. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Some aspects of clinical use of nitric oxide in pulmonary hypertension].
    Cheng X; He J
    Zhonghua Yi Xue Za Zhi; 1998 Jan; 78(1):6-7. PubMed ID: 10923395
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sildenafil in pulmonary hypertension].
    Ewert R; Höper M; Halank M; Winkler J; Wensel R; Opitz C
    Pneumologie; 2003 May; 57(5):291; author reply 291-2; discussion 292. PubMed ID: 12825577
    [No Abstract]   [Full Text] [Related]  

  • 39. The pathology of primary pulmonary hypertension.
    Burke AP; Farb A; Virmani R
    Mod Pathol; 1991 Mar; 4(2):269-82. PubMed ID: 2047387
    [No Abstract]   [Full Text] [Related]  

  • 40. [Primary pulmonary hypertension].
    Simarro E; Barriales V
    Med Clin (Barc); 1988 Mar; 90(11):469-73. PubMed ID: 3290596
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.